Clinical Trial Detail

NCT ID NCT03353753
Title Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC
Indications

gastrointestinal stromal tumor

Therapies

Ripretinib

Age Groups: senior adult

No variant requirements are available.